2024 Q4 Form 10-Q Financial Statement

#000121390024097441 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $820.6K
YoY Change 1496.61%
Cost Of Revenue $770.5K
YoY Change 1123.85%
Gross Profit $50.14K
YoY Change -533.78%
Gross Profit Margin 6.11%
Selling, General & Admin $102.8K
YoY Change
% of Gross Profit 205.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $102.8K
YoY Change -25.05%
Operating Profit -$52.69K
YoY Change -64.58%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.00
YoY Change -1000.0%
Pretax Income -$50.19K
YoY Change -64.32%
Income Tax -$5.421K
% Of Pretax Income
Net Earnings -$61.06K
YoY Change -57.74%
Net Earnings / Revenue -7.44%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 518.8M shares 518.8M shares 518.8M shares
Diluted Shares Outstanding 518.8M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $307.0K $895.7K
Short-Term Investments
Other Short-Term Assets $1.062M $1.142M
YoY Change 24.99% 36398.69%
Inventory $1.855M $13.71K
Prepaid Expenses $23.32K
Receivables $291.3K $742.9K
Other Receivables $57.85K $1.107M
Total Short-Term Assets $4.372M $3.961M
YoY Change 56.63% 12123.0%
LONG-TERM ASSETS
Property, Plant & Equipment $19.31K $3.193K
YoY Change
Goodwill
YoY Change
Intangibles $2.993K $3.213K
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.493M $706.9K
YoY Change 430.65%
Total Long-Term Assets $57.74M $46.25M
YoY Change 29.78%
TOTAL ASSETS
Total Short-Term Assets $4.372M $3.961M
Total Long-Term Assets $57.74M $46.25M
Total Assets $62.11M $50.22M
YoY Change 31.37% 154867.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $119.8K $385.8K
YoY Change 58.58% 35.33%
Deferred Revenue $29.54K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $38.50K
YoY Change
Total Short-Term Liabilities $542.4K $1.055M
YoY Change -93.24% -47.37%
LONG-TERM LIABILITIES
Long-Term Debt $6.449M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $20.86M $8.672M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $542.4K $1.055M
Total Long-Term Liabilities $20.86M $8.672M
Total Liabilities $21.40M $9.728M
YoY Change 166.72% 385.17%
SHAREHOLDERS EQUITY
Retained Earnings -$1.035M -$812.5K
YoY Change 25.27% -95.91%
Common Stock $40.42M $518.8K
YoY Change 7691.37% -49.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.65M $40.49M
YoY Change
Total Liabilities & Shareholders Equity $62.11M $50.22M
YoY Change 31.37% 154867.19%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$61.06K
YoY Change -57.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-26731
dei Entity Registrant Name
EntityRegistrantName
Hongchang International Co., Ltd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0627910
dei Entity Address Address Line1
EntityAddressAddressLine1
Block 20
dei Entity Address Address Line2
EntityAddressAddressLine2
Hongchang Food Co., Ltd., Yuanhong Investment Zone
dei Entity Address Address Line3
EntityAddressAddressLine3
Donggao Village
dei Entity Address City Or Town
EntityAddressCityOrTown
Fuzhou City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
350300
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
(86)
dei Local Phone Number
LocalPhoneNumber
180 5901 6050
dei Security12b Title
Security12bTitle
None
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
518831367 shares
CY2024Q3 us-gaap Cash
Cash
307049 usd
CY2023Q4 us-gaap Cash
Cash
895730 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
291266 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
742851 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
57846 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1106574 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1855356 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13713 usd
CY2024Q3 us-gaap Supplies
Supplies
799273 usd
CY2023Q4 us-gaap Supplies
Supplies
13811 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1061613 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1128598 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
4372403 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3960742 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19305 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193 usd
CY2024Q3 hcil Construction In Progress Net
ConstructionInProgressNet
44133659 usd
CY2023Q4 hcil Construction In Progress Net
ConstructionInProgressNet
41423399 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2993 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3213 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4090369 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4118101 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9492501 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
706920 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
57738827 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
46254826 usd
CY2024Q3 us-gaap Assets
Assets
62111230 usd
CY2023Q4 us-gaap Assets
Assets
50215568 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
38495 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
155864 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
650905 usd
CY2024Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
16239 usd
CY2023Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
18493 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29537 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119791 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
385805 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
542440 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1055203 usd
CY2024Q3 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
2008175 usd
CY2023Q4 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
1989463 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6448688 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20856491 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8672422 usd
CY2024Q3 us-gaap Liabilities
Liabilities
21398931 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9727625 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
518831367 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518831367 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
518831367 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518831367 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
518831 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
518831 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39905228 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39905228 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1034975 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-812539 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1262357 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
876423 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
40651441 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
40487943 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
60858 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40712299 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40487943 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62111230 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50215568 usd
CY2024Q3 us-gaap Revenues
Revenues
820608 usd
CY2023Q3 us-gaap Revenues
Revenues
51397 usd
us-gaap Revenues
Revenues
2820710 usd
us-gaap Revenues
Revenues
78204 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
770472 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
62955 usd
us-gaap Cost Of Revenue
CostOfRevenue
2672132 usd
us-gaap Cost Of Revenue
CostOfRevenue
104430 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
50136 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-11558 usd
us-gaap Gross Profit
GrossProfit
148578 usd
us-gaap Gross Profit
GrossProfit
-26226 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1382 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1573 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101442 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
137193 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
326016 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
381579 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
102824 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
137193 usd
us-gaap Operating Expenses
OperatingExpenses
327589 usd
us-gaap Operating Expenses
OperatingExpenses
381579 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-52688 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-148751 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-179011 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-407805 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
177 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
453 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1082 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
924 usd
CY2024Q3 us-gaap Other Income
OtherIncome
2328 usd
CY2023Q3 us-gaap Other Income
OtherIncome
7630 usd
us-gaap Other Income
OtherIncome
3484 usd
us-gaap Other Income
OtherIncome
18309 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-155 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50192 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-140667 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174600 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-388609 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5421 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3826 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11580 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3826 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-44771 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-144493 usd
us-gaap Profit Loss
ProfitLoss
-163020 usd
us-gaap Profit Loss
ProfitLoss
-392435 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16289 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
59413 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-61060 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-144493 usd
us-gaap Net Income Loss
NetIncomeLoss
-222433 usd
us-gaap Net Income Loss
NetIncomeLoss
-392435 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-44771 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-144493 usd
us-gaap Profit Loss
ProfitLoss
-163020 usd
us-gaap Profit Loss
ProfitLoss
-392435 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1456463 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-463178 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
387376 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-356177 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1411692 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-607671 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
224356 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-748612 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
18132 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
60858 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1393560 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-607671 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
163498 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-748612 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518831367 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518831367 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449998706 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
449998706 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518831367 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518831367 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449998706 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
449998706 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40487943 usd
us-gaap Profit Loss
ProfitLoss
-163020 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
387376 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40712299 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-418653 usd
us-gaap Profit Loss
ProfitLoss
-392435 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-356177 usd
hcil Stock Issued During Period Value Contribution From Shareholder
StockIssuedDuringPeriodValueContributionFromShareholder
41241108 usd
hcil Stock Issued During Period Value Deemed Issuance Of Share Upon The Merger Transaction
StockIssuedDuringPeriodValueDeemedIssuanceOfShareUponTheMergerTransaction
-817049 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39256794 usd
us-gaap Profit Loss
ProfitLoss
-163020 usd
us-gaap Profit Loss
ProfitLoss
-392435 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
67258 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59602 usd
hcil Accrued Interest Income Derived From Loan To Third Party
AccruedInterestIncomeDerivedFromLoanToThirdParty
18026 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16222 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-447683 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1797790 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26405 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
794470 usd
hcil Increase Decrease Advance To Supplierrelated Party
IncreaseDecreaseAdvanceToSupplierrelatedParty
-58460 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
24395 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-91981 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
862632 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-489264 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
178180 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-263138 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2821 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
28836 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10913 usd
us-gaap Government Assistance Asset Increase
GovernmentAssistanceAssetIncrease
2003319 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2675911 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
777143 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10856228 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40391648 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
139 usd
hcil Repayments From A Third Party Investing
RepaymentsFromAThirdPartyInvesting
-1086307 usd
us-gaap Payments For Investment In Restricted Cash From Pollution Control Bond
PaymentsForInvestmentInRestrictedCashFromPollutionControlBond
131 usd
hcil Payments Of Loan To Third Party
PaymentsOfLoanToThirdParty
1015527 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9769913 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41407175 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
41241108 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
6333153 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2413571 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2660425 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7943309 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1792987 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11862891 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40373670 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5748 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1116340 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-588681 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
859978 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
895730 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3141 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307049 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
863119 usd
us-gaap Interest Paid
InterestPaid
208243 usd
us-gaap Interest Paid Net
InterestPaidNet
222248 usd
hcil Other Receivable From Disposal Of Subsidiary
OtherReceivableFromDisposalOfSubsidiary
27924 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>1. ORGANIZATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><b><i>(a) Nature of operations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Hongchang International Co., Ltd (the “Company”) was incorporated in the state of Nevada on May 18, 1987. The Company is a holding company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 4, 2023, Heyu Biological Technology Corporation (“HYBT”), the Company’s predecessor, completed the merger and other related transactions (the “Merger Transactions”) with Hongchang Global Investment Holdings Limited (“Hongchang BVI”), as a result of which Hongchang BVI became a wholly-owned subsidiary of HYBT and HYBT assumed and began conducting the principal business of Hongchang BVI. The name of the Company was changed from “Heyu Biological Technology Corporation” to “Hongchang International Co., Ltd.” (HCIL).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The “Group” means (i) prior to the completion of the Reorganization, Hongchang BVI and its subsidiaries that engage in businesses of food trade and biotechnology in China (ii) upon and after completion of the Merger Transactions, the Company and its subsidiaries that engage in businesses of food trade and meat processing in China.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><b><i>(b) History and reorganization of the Group</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparation of the Merger Transactions, the following transactions were undertaken to reorganize the legal structure of Operating Entity (“Reorganization”). On January 13, 2023, Mr. Zengqiang Lin and Ms. Zhenzhu Lin, the existing stockholders of Fuqing Hongchang Food Co., Ltd (“Hongchang Food”) established two wholly-owned subsidiaries (“BVI-1” and “BVI-2”) in British Virgin Island, respectively. On January 18, 2023, Hong Chang Global Investment Holdings Limited (“Hongchang BVI”) was then incorporated by BVI-1 and BVI-2 which held 70% and 30% equity interest of Hongchang BVI, respectively. On February 6, 2023, Hongchang BVI incorporated a wholly-owned subsidiary, Hong Chang Biotechnologies (HK) Limited (“Hongchang HK”). On February 28, 2023, Hongchang HK incorporated a wholly-owned subsidiary, Fujian Hongjin Biotechnology Co., Ltd. (“WFOE”) in the People’s Republic of China (“PRC”). WFOE then purchased the total equity interest of Hongchang Food. After the Reorganization, Mr. Zengqiang Lin and Ms. Zhenzhu Lin hold 70% and 30% equity interest of Hongchang Food through WFOE, respectively. As all the entities involved in the process of the Reorganization are under common ownership of Hongchang Food’s stockholders before and after the Reorganization, the Reorganization is accounted for in a manner similar to a pooling of interests with the assets and liabilities of the parties to the Reorganization carried over at their historical amounts. Therefore, the accompanying unaudited condensed consolidated financial statements were prepared as if the corporate structure of the Group had been in existence since the beginning of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>(c) Reverse merger</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 21, 2023, HYBT entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Hongchang BVI and Hongchang BVI’s stockholders, Zengqiang Investment Limited, a business company incorporated in the BVI, and Hong Jin Investment Limited, a business company incorporated in the BVI (the “Selling Stockholders” and each a “Selling Stockholder”), in relation to the acquisition of Hongchang BVI by HYBT (the “Hongchang Acquisition”). Zengqiang Investment Limited is wholly-owned by Mr. Zengqiang Lin and Hong Jin Investment Limited is wholly-owned by Ms. Zhenzhu Lin. Mr. Zengqiang Lin has been a director of HYBT since February 17, 2023, and Ms. Zhenzhu Lin is the sister of Mr. Zengqiang Lin. In accordance with the terms of the Share Exchange Agreement, the Selling Stockholders sold and transferred 100 shares of Hongchang BVI, constituting all of the issued and outstanding share capital of Hongchang BVI, to HYBT in exchange for an aggregate of 415,582,375 new shares of HYBT’s common stock (the “Consideration Shares”), of which 353,322,843 shares were issued to Zengqiang Investment Limited and 62,259,532 shares were issued to Hong Jin Investment Limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately following the closing of the Hongchang Acquisition, HYBT had a total of 518,831,367 issued and outstanding shares of common stock. The 415,582,375 Consideration Shares constitute 80.1% of its enlarged share capital following the closing of the Hongchang Acquisition. The exchange consideration for the Hongchang Acquisition was determined on an arms’ length basis based on our valuation of Hongchang BVI and its subsidiaries and its assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As HYBT, the legal acquirer and accounting acquiree, does not meet the definition of a business, management concluded that the Merger should be accounted for as a continuation of the financial statements of Hongchang BVI (the legal subsidiary), together with a deemed issue of shares and a re-capitalization of the equity of Hongchang BVI. Hongchang BVI is the continuing entity and is deemed to have issued shares in exchange for the identifiable net assets held by HYBT together with the listing status of HYBT. Management concluded that September 4, 2023 is the acquisition date of the Merger.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the completion of the reverse merger, the Company has set up a few new subsidiaries: Fujian Hongchang Global Food Co., Ltd (“Hongchang Global Food”), Fuqing Hongchang Global Import &amp; Export Co., Ltd (“Hongchang Import &amp; Export”), Fuqing Hongchang Global Supply Chain Co., Ltd (“Hongchang Supply Chain”), and Hongchang Global (Fuqing City) Agricultural Technology Development Co., Ltd (“Hongchang Agricultural”) in order for the company to develop different businesses. As of the date of this report, these subsidiaries have not generated significant revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2024, the Company set up a new subsidiary Hongfu Food (Fujian) Co., Ltd (“Hongfu Food”), which is mainly engaged in the initial processing of agricultural products, specializing in pork segmentation and trade. Hongfu Food purchasing pork as raw materials and processing or dividing them into various finished products according to customer needs, or through secondary segmentation into various specifications of packed finished products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on above transactions, the accompanying unaudited condensed consolidated financial statements reflect the activities of each of the following entities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of <br/> incorporation</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of <br/> direct or indirect <br/> ownership <br/> by the Company</b></span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Subsidiaries:</span></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 47%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Chang Global Investment Holdings Limited (Hongchang BVI)</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Virgin Island</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment holding</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Chang Biotechnologies (HK) Limited (Hongchang HK)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment holding</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fujian Hongjin Biotechnology Co., Ltd. (WFOE)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of technical and consultation services</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Food Co., Ltd (Hongchang Food)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of Food Industry Park operation, food trade and meat processing</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fujian Hongchang Global Food Co., Ltd (“Hongchang Global Food”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade </span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Global Import &amp; Export Co., Ltd (“Hongchang Import&amp;Export”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade </span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fuqing Hongchang Global Supply Chain Co., Ltd (“Hongchang Supply Chain”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hongchang Global (Fuqing City) Agricultural Technology Development Co., Ltd (“Hongchang Agricultural”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%, disposed on September 3, 2024</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade and biotechnology</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hongfu Food (Fujian) Co., Ltd (“Hongfu Food”)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51%</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision of food trade and meat processing</span></td></tr> </table>
CY2024Q3 hcil Percentage Of Share Capital
PercentageOfShareCapital
0.801 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenue and expenses during the reported period in the unaudited condensed consolidated financial statements and accompanying notes. Significant accounting estimates reflected in the Group’s unaudited condensed consolidated financial statements mainly include, but are not limited to, assessment for impairment of long-lived assets, valuation of deferred tax assets, current expected credit loss of receivables, and valuation of inventory and advance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the unaudited condensed consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Group to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.</p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
70000 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000 cny
us-gaap Insured Event Gain Loss
InsuredEventGainLoss
155359 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
222248 usd
CY2024Q3 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
2008175 usd
CY2023Q4 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
1989463 usd
CY2023Q2 hcil Capital Contribution
CapitalContribution
41241108 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1034975 usd
us-gaap Profit Loss
ProfitLoss
-163020 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
41241108 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Statement Reclassification </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain balances in the prior year unaudited condensed consolidated financial statements have been reclassified for comparison purposes to conform to the presentation in the current year unaudited condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations or financial position.</p>
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
291266 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
742851 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
291266 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
742851 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1079127 usd
CY2024Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
57846 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
27447 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
57846 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1106574 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1079127 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32403 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1822953 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13713 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
1855356 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
13713 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1855356 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13713 usd
CY2024Q3 us-gaap Supplies
Supplies
799273 usd
CY2023Q4 us-gaap Supplies
Supplies
13811 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
59324 usd
CY2024Q3 hcil Advance To Supplier
AdvanceToSupplier
799273 usd
CY2023Q4 hcil Advance To Supplier
AdvanceToSupplier
73135 usd
CY2024Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
978518 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1039421 usd
CY2024Q3 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
83095 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
65858 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23319 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1061613 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1128598 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21672 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3381 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2367 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
188 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19305 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193 usd
us-gaap Depreciation
Depreciation
2126 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
44133659 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
41423399 usd
CY2024Q3 hcil Construction In Progress Net
ConstructionInProgressNet
44133659 usd
CY2023Q4 hcil Construction In Progress Net
ConstructionInProgressNet
41423399 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3326 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3295 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
333 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
82 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2993 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3213 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
243 usd
CY2024Q3 us-gaap Land
Land
4430089 usd
CY2023Q4 us-gaap Land
Land
4388808 usd
CY2024Q3 hcil Less Accumulated Amortization
LessAccumulatedAmortization
339720 usd
CY2023Q4 hcil Less Accumulated Amortization
LessAccumulatedAmortization
270707 usd
CY2024Q3 hcil Land Use Right Net
LandUseRightNet
4090369 usd
CY2023Q4 hcil Land Use Right Net
LandUseRightNet
4118101 usd
hcil Land Use Right Term
LandUseRightTerm
P50Y
CY2024Q3 hcil Advance Payment For Construction Gross
AdvancePaymentForConstructionGross
9492501 usd
CY2023Q4 hcil Advance Payment For Construction Gross
AdvancePaymentForConstructionGross
706920 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9492501 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
706920 usd
CY2024Q3 hcil Advance Payment For Construction
AdvancePaymentForConstruction
9492501 usd
CY2023Q4 hcil Advance Payment For Construction
AdvancePaymentForConstruction
706920 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
108518 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
92262 usd
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2245 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
239543 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9028 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119791 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
385805 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
6487183 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
76991 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
142575 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
142575 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
273745 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
5851297 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
6487183 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
38495 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6448688 usd
us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
222248 usd
CY2023Q1 hcil Numberof Allotted Shares
NumberofAllottedShares
100 shares
CY2023Q1 us-gaap Share Price
SharePrice
1
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
100 shares
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
CY2023Q1 us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
100 shares
CY2023Q2 hcil Capital Contribution
CapitalContribution
41241108 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7943309 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1792987 usd
hcil Refunds From A Related Party
RefundsFromARelatedParty
58599 usd
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
60000000 cny
CY2023Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
8600000 usd
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
30000000 cny
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
4300000 usd
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
20000000 cny
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2900000 usd
CY2024Q3 us-gaap Other Commitment
OtherCommitment
13087649 usd
CY2023Q4 us-gaap Other Commitment
OtherCommitment
23698063 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
hcil Accrued Interest Income Derived From Loan To Third Party
AccruedInterestIncomeDerivedFromLoanToThirdParty
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
usd
hcil Increase Decrease Advance To Supplierrelated Party
IncreaseDecreaseAdvanceToSupplierrelatedParty
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
usd
us-gaap Government Assistance Asset Increase
GovernmentAssistanceAssetIncrease
usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
usd
hcil Repayments From A Third Party Investing
RepaymentsFromAThirdPartyInvesting
usd
hcil Payments Of Loan To Third Party
PaymentsOfLoanToThirdParty
usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
hcil Other Receivable From Disposal Of Subsidiary
OtherReceivableFromDisposalOfSubsidiary
usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Advertising Expense
AdvertisingExpense
usd
us-gaap Advertising Expense
AdvertisingExpense
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2024Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
usd
CY2024Q3 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
usd
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
usd
us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001086303

Files In Submission

Name View Source Status
0001213900-24-097441-index-headers.html Edgar Link pending
0001213900-24-097441-index.html Edgar Link pending
0001213900-24-097441.txt Edgar Link pending
0001213900-24-097441-xbrl.zip Edgar Link pending
ea0220018-10q_hongchang.htm Edgar Link pending
ea022001801ex31-1_hongchang.htm Edgar Link pending
ea022001801ex31-2_hongchang.htm Edgar Link pending
ea022001801ex32-1_hongchang.htm Edgar Link pending
ea022001801ex32-2_hongchang.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hcil-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
hcil-20240930_cal.xml Edgar Link unprocessable
hcil-20240930_def.xml Edgar Link unprocessable
hcil-20240930_lab.xml Edgar Link unprocessable
hcil-20240930_pre.xml Edgar Link unprocessable
ea0220018-10q_hongchang_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable